Cost Effectiveness and Resource Allocation

Papers
(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency99
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea84
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value56
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran37
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia37
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness36
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique34
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study33
Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma23
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial23
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?20
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis18
The relative cost-effectiveness of atraumatic needles compared to conventional needles in diagnostic lumbar punctures18
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model18
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening18
Budget impact of expanded hemodialysis versus high-flux hemodialysis using real-world evidence in Colombia16
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi16
Benefit-cost analysis of nonprofit cataract surgery services in Latin America: a multinational evaluation through an SROI lens16
Economic burden of knee joint replacement in Iran16
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model16
Post-COVID-19 condition patients’ utilisation of healthcare resources after implementation of an integrated care unit15
Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia15
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study15
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”15
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study in 202114
When is elimination of an infectious disease cost-effective? An analytical framework to guide elimination priorities13
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients13
A systemmatic literature review on indirect costs of women with breast cancer13
Early budget impact analysis of magnetic balloon technology for facilitating the completion of difficult colonoscopies13
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review13
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China12
A gender perspective of smoking cessation’s health and economic value in Jordanian women: using cost effectiveness model12
Cost-effectiveness analysis of surgical proximal femur fracture prevention in elderly: a Markov cohort simulation model12
Individual-level prediction models of societal costs and health-related quality of life in pediatric cerebral palsy: a population-based study from Spain12
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—202311
Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia11
Reducing unnecessary coagulation screening in ambulatory patients in the emergency departments of a multi-site trust: a quality improvement project11
Expenditure and use on radiology imaging in urban and rural areas in a developing country11
Disease-specific distress healthcare financing and catastrophic out-of-pocket expenditure for hospitalization care in Bangladesh11
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study11
Why will increasing medical insurance reimbursement levels not lead to over-medicalization? Evidence from China’s medical insurance payment reform11
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer10
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality10
An investigation of the quality of Syrian health insurance services via the SERVQUAL approach: a cross-sectional study10
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?10
The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland10
Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports10
The effect of hospital budgeting system on physician-executives’ budget cognitive consciousness and medical decision making10
The cost of delivering COVID-19 vaccines in four districts in Malawi10
Operationalizing game-theoretic weighting in public hospital cost control: an implementation framework from Chinese tertiary hospitals10
Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States9
Regional disparities, dynamic evolution, and spatial spillover effects of medical resource allocation efficiency in TCM hospitals9
Analysis of costs in implementing the HEARTS hypertension program in Nigerian primary care9
IAPN: a simple framework for evaluating whether a population-based risk stratification tool will be cost-effective before implementation9
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases9
Epidemiological and economic impact of pre-exposure prophylaxis with targeted immunotherapies for COVID-19 among immunosuppressed patients in Argentina9
Does healthcare expenditure matter equally for all mental disorders? An international approach employing dynamic panel data methods9
Assessing diagnosis-related groups based direct medical expenditures of chronic disease patients in general hospital of lower southern Thailand9
Review for cost-effectiveness analysis of laparoscopic Intra-peritoneal Onlay Mesh for ventral hernia repair in Indian settings9
Cost-consequence analysis of a digital health-enabled non-communicable disease management intervention in Ghana8
Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda8
The stochastic frontier analysis technique in measuring the technical and economic efficiency of hospital diagnostic laboratories: a case study in Iran8
What are economic costs and when should they be used in health economic studies?8
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective8
A Markov modeling framework for estimating the effects of asthma medication adherence on healthcare use and costs in pediatric asthma8
How much do lower respiratory tract infections in adults cost? A hospital-based cost analysis in Colombia8
Cost-effectiveness analysis of different tracers (Patent Blue, Technetium-99 m, and Indocyanine Green) for Sentinel Lymph Node Biopsy procedure in breast cancer7
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer7
The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas7
From pilot to national roll-out of the improved Community Health Fund (iCHF) in Tanzania: lessons learnt and way forward7
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning7
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method7
Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments7
Factors influencing the demand for individual voluntary private health insurance in Iran7
Costs of fall injuries in the STRIDE study: an economic evaluation of healthcare system heterogeneity and heterogeneity of treatment effect7
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma7
Economic burden of knee replacement, a case of Bushehr, Iran in 2023–20247
Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective7
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study7
A cost-benefit analysis of mass prostate cancer screening7
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran7
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier7
The role of routine chest radiography after implantable venous access port catheter insertion under the guide of ultrasonography and fluoroscopy6
Economic burden of breast cancer: a case of Southern Iran6
Cost-effectiveness analysis of COVID-19 tests in the unified health system6
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye6
Population ageing and sustainability of healthcare financing in China6
Willingness to join community-based health insurance and associated factors among households in Ethiopian: a systematic review and meta-analysis6
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis6
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach6
Comparative Efficiency Analysis of OECD Health Systems: FDH vs. Machine Learning Approaches with Efficiency Analysis Trees (EAT and RFEAT)6
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review6
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer6
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?6
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis5
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting5
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review5
Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy5
The value of admission avoidance: cost-consequence analysis of one-year activity in a consolidated service5
Analysis on the individual and allocation efficiencies of health resources in China: 2008–20215
Cost-effectiveness of short-term parent-infant-psychotherapy, results from two randomized controlled trials5
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China5
A health economics assessment of self-care with over-the-counter ibuprofen in dysmenorrhoea, migraine and acute rhinosinusitis in the United Kingdom5
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru5
The burden of health expenditure on household impoverishment in Ethiopia: a systematic review and meta-analysis5
Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses5
Cost-effectiveness analysis of an implantable cardiac defibrillator compared with pharmaceutical therapy in patients hospitalized with arrhythmia in Iran5
Correction to: Medical expenses and its determinants in female patients with urological disorder5
Diagnosis-Related group payment and its impact on hospitalization costs and patient financial protection for neurointerventional stroke care in a Chinese tertiary hospital: a retrospective analysis5
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran5
Cost-effectiveness analysis of home-based palliative care for end-stage cancer patients5
Cost-effectiveness of paramedic administered ketamine compared to morphine for the management of acute severe pain from traumatic injury5
Ghana’s Diagnosis Related Grouping (G-DRG) tariffs versus hospital charges: implications for inpatient care financing at a secondary hospital in Ghana5
Strategic analysis of financing communicable diseases in Afghanistan5
Drivers of sustainable procurement in the health sector: perspectives from key informant interviews of two teaching hospitals in Ghana5
0.057675838470459